EP 1414489 A2 20040506 - ANTIALLERGIC PHARMACEUTICAL COMPOSITION
Title (en)
ANTIALLERGIC PHARMACEUTICAL COMPOSITION
Title (de)
ANTIALLERGISCHE PHARMAZEUTISCHE ZUSAMMENSETZUNG, WELCHE EINEN INHIBITOR DER HISTAMINSYNTHESE UND EIN ANTIHISTAMINIKUM ENTHÄLT
Title (fr)
COMPOSITION PHARMACEUTIQUE ANTI-ALLERGIQUE COMPRENANT UN COMPOSE ANTIHISTAMINIQUE ET UN INHIBITEUR DE SYNTHESE D'HISTAMINE
Publication
Application
Priority
- FR 0201098 W 20020328
- FR 0104370 A 20010330
- FR 0105929 A 20010503
- US 86715901 A 20010529
Abstract (en)
[origin: WO02078736A2] The invention concerns an antiallergic pharmaceutical composition characterised in that it comprises: (i) an antihistaminic compound, (ii) an inhibitor of histamine synthesis, and optionally (iii) an allergen or an isolated nucleic acid molecule comprising at least a polynucleotide sequence coding for said allergen, the constituents being combined in said composition with a pharmaceutically acceptable carrier,
IPC 1-7
IPC 8 full level
A61K 31/00 (2006.01); A61K 38/48 (2006.01); A61K 39/35 (2006.01); A61K 45/06 (2006.01); A61P 37/08 (2006.01)
CPC (source: EP US)
A61K 39/35 (2013.01 - EP US); A61K 45/06 (2013.01 - EP US); A61P 37/08 (2017.12 - EP)
Citation (search report)
See references of WO 02078736A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 02078736 A2 20021010; WO 02078736 A3 20040219; AT E342732 T1 20061115; AU 2002308044 A1 20021015; BR 0208710 A 20040824; DE 60215548 D1 20061130; EP 1414489 A2 20040506; EP 1473041 A2 20041103; EP 1473041 A3 20041124; EP 1473041 B1 20061018; FR 2822709 A1 20021004; FR 2822709 B1 20070119; US 2003104013 A1 20030605; US 7048928 B2 20060523
DOCDB simple family (application)
FR 0201098 W 20020328; AT 04007143 T 20020328; AU 2002308044 A 20020328; BR 0208710 A 20020328; DE 60215548 T 20020328; EP 02757745 A 20020328; EP 04007143 A 20020328; FR 0105929 A 20010503; US 86715901 A 20010529